Joomla! provides plenty of flexibility when displaying your Web content. Whether you are using Joomla! for a blog site, news or a Web site for a company, you'll find one or more content styles to showcase your information. You can also change the style of content dynamically depending on your preferences. Joomla! calls how a page is laid out a layout. Use the guide below to understand which layouts are available and how you might use them.
Speakers of WMS 2022 Congress
 Keynote Speech - Mitochondrial Medicine : Present and Future Douglas C. Wallace, Children's Hospital of Philadelphia, USA |
|
James McCully, Boston Children’s Hospital, USA
|
 Jan Smeitink, Khondrion B.V., the Netherlands
|
Lori Buhlman, Midwestern University Glendale, USA
|
 Mitochondrial and Photo-Medicine - Recent Clinical ApplicationsMichael Weber, President of European Laser Academy, Germany |
Marc Germain, Université du Québec à Trois-Rivières, Canada
|
 Mitochondrial, Exosomal miR137-COX6A2 in Schizophrenia
Ines Khadimallah, Lausanne University Hospital, Switzerland
|
 The Potential of Mitochondrial Genome Engineering Pedro Silva-Pinheiro, University of Cambridge, United Kingdom
|
 GM1 oligosaccharide as mitochondrial modulator: implications in neurological diseases Maria Fazzari, University of Milano, Italy
|
| Jessica Spinelli, Whitehead Institute for Biomedical Research, USA |
|
Marc G. Jeschke, University of Toronto, Canada
|
| Ian J. Holt, Biodonostia Health Research Institute, Spain |
|
Michael Teitell, University of California, USA
|
|
Raghavan Pillai Raju, Medical College of Georgia, USA
|
|
Camilla Bean, University of Padova, Italy
|
|
Qun Sophia Zang, Loyola University Chicago Health Science Campus, USA
|
 Mitochondria Transplantation Between Living CellsJulia A. Vorholt, ETH Zurich, Switzerland
|
 A Non-canonical Tricarboxylic Acid Cycle Underlies Cellular IdentityPaige Arnold, Memorial Sloan Kettering Cancer Center, USA
|
 Noninvasive treatment of brain ischemia-reperfusion injury with near infrared light: working toward clinical implementationMaik Hüttemann, Wayne State University, USA
|
 Autologous Mitochondrial Transplant for Cerebral Ischemia
Melanie Walker, University of Washington Medical School, USA
|
|
Anna Krasnodembskaya, Queen's University Belfast, United Kingdom
|
 |
Dhyan Chandra, Roswell Park Comprehensive Cancer Center, USA |
|
John Ball, National Institutes of Health, USA
|
 How to Evaluate Mitochondria Function?
Naig Gueguen, Mitovasc Institute, Mitolab team, INSERM 1083, CNRS 6215, Centre Hospitalier Universitaire d’Angers, France |
Welcome to Targeting Mitochondria 2021
On behalf of the Scientific Committee of the World Mitochondria Society (WMS), we are excited to announce that the 13th World Annual Meeting of WMS on Targeting Mitochondria will be held as on for October 26-28, 2022 in Berlin, Germany.
After the great success of the 12nd WMS Meeting in 2021 that was held virtually with interactive sessions for discussion, we are hoping that personal interactions among colleagues from around the world will be a major feature of our 13th World Annual Meeting.
While we have just started working on the outline of our next conference edition, we will potentially discuss the following topics:
- Mitochondrial Dysfunctions and Dynamics in Chronic Diseases
- Mitochondria transplantation and mitochondrial transfer
- Extracellular vesicles, exosomes and mitochondria
- Mitochondria and Immunity – Covid-19 and Cancer
- Nuclear-Mitochondrial Interactions and their Effect on Longevity and Health
- Strategies to Target Mitochondria: Clinical Trials and Potential Mitochondria-based Therapies
Basic scientists working at the bench in the laboratory, physicians treating patients suffering from mitochondrial disorders as well as representatives of companies working on the commercialization of mitochondria-targeted therapies are all welcome to our conference. I assure anyone who is going to join us in this year's Congress in October 2022 that you won’t be disappointed!
We are looking forward to meeting you all!
All our warmest regards.
|
|
 Prof. Marvin Edeas, Founder of the World Mitochondria Society Institut Cochin, INSERM U1016, University Paris Descartes, France |
President's Note: Targeting Mitochondria 2022
On behalf of the Scientific Committee of the World Mitochondria Society (WMS), we are pleased to announce the organization of the 13th Annual Meeting of WMS on Targeting Mitochondria, which will be held on October 26-28, 2022 at the Steigenberger Hotel Am Kanzleramt, Berlin, Germany & Online.
After the great success of the 12thWMS Meeting in 2021 that was held virtually with interactive sessions for discussion, we are hoping that personal interactions among colleagues from around the world will be a major feature of our 13th World Annual Meeting.
While we have just started working on the outline of our next conference edition, we will potentially discuss the following topics:
- Mitochondrial Dysfunctions and Dynamics in Chronic Diseases
- Mitochondria Transplantation and Transfer
- Extracellular Vesicles & Mitochondria: The Target
- Nuclear-Mitochondrial Interactions and their Effect on Longevity and Health
- Translational Therapies - Focus on Infrared Therapies
- WMS challenges in the Acceleration of Mitochondrial Medicine
Basic scientists working at the bench in the laboratory, physicians treating patients suffering from mitochondrial disorders as well as representatives of companies working on the commercialization of mitochondria-targeted therapies are all welcome to our conference. I assure anyone who is going to join us in this year's Congress in October 2022 that you won’t be disappointed!
We are looking forward to meeting you all!
All our warmest regards.
|
|
 Prof. Marvin Edeas, Founder of the World Mitochondria Society Institut Cochin, INSERM U1016, University Paris Descartes, France |
